XML 31 R25.htm IDEA: XBRL DOCUMENT v2.4.1.9
Description of Business, Basis of Consolidation and Significant Accounting Policies (Tables)
12 Months Ended
Dec. 31, 2014
Summary of Business Sales and Gross Profit Information

Based on similar economic and operational characteristics, the Company’s business is aggregated into one reportable segment. Selective enterprise information is as follows:

 

     2014      2013      2012  

Net sales:

        

Insecticides

   $ 135,705       $ 193,623       $ 194,060   

Herbicides/soil fumigants/fungicides

     101,785         121,042         89,899   

Other, including plant growth regulators

     30,220         31,849         45,581   
  

 

 

    

 

 

    

 

 

 

Total crop

  267,710      346,514      329,540   

Non-crop

  30,924      34,507      36,650   
  

 

 

    

 

 

    

 

 

 
$ 298,634    $ 381,021    $ 366,190   
  

 

 

    

 

 

    

 

 

 

Gross profit:

Crop

$ 101,633    $ 155,275    $ 142,019   

Non-crop

  12,863      16,072      19,106   
  

 

 

    

 

 

    

 

 

 
$ 114,496    $ 171,347    $ 161,125   
  

 

 

    

 

 

    

 

 

 
Summary of Operating Expense

Operating expenses include cost centers for Selling, General and Administrative, Research, Product Development, and Regulatory, Freight, Delivery and Warehousing.

 

     2014      2013      2012  

Selling

   $ 31,593       $ 32,929       $ 25,869   

General and administrative

     27,057         33,536         29,715   

Research, product development and regulatory

     21,206         21,644         20,750   

Freight, delivery and warehousing

     27,930         27,503         25,468   
  

 

 

    

 

 

    

 

 

 
$ 107,786    $ 115,612    $ 101,802   
  

 

 

    

 

 

    

 

 

 

Components of Inventories

The components of inventories consist of the following:

 

     2014      2013  

Finished products

   $ 142,853       $ 126,872   

Raw materials

     22,778         12,958   
  

 

 

    

 

 

 
$ 165,631    $ 139,830   
  

 

 

    

 

 

 
Impact of Derivatives on Statement of Operations

The following tables illustrate the impact of derivatives on the Company’s statement of operations for the year ended December 31, 2014 and 2013.

 

The Effect of Derivative Instruments on the Statement of Financial Performance

For the Period Ended December 31

 
Derivatives in ASC 815 Cash Flow    Amount of Gain or
(Loss) Recognized in
OCI on Derivative
(Effective Portion)
    Location of Gain or
(Loss) Reclassified
from Accumulated
OCI into Income
   Amount of Gain or
(Loss) Reclassified
from Accumulated
OCI into Income
(Effective Portion)
    Location of Gain or
(Loss) Recognized in
Income on Derivative
   Amount of Gain or
(Loss) Recognized
in Income on
Derivative
(Ineffective Portion)
 

Hedging Relationships

   2014     2013     (Effective Portion)    2014     2013     (Ineffective Portion)    2014     2013  

Interest rate contracts

   $ (30   $ (75   Interest expense    $ (594   $ (712   Interest expense    $ (3   $ (1
  

 

 

   

 

 

      

 

 

   

 

 

      

 

 

   

 

 

 

Total

$ (30 $ (75 $ (594 $ (712 $ (3 $ (1
  

 

 

   

 

 

      

 

 

   

 

 

      

 

 

   

 

 

 
Foreign Currency Derivatives to Hedge Foreign Currency Balances Measured at Fair Value
     Fair Value Measurements
Using Input Type
 
     Level 1      Level 2      Level 3  

As of December 31, 2013:

        

Liability:

        

Interest rate derivative financial instruments (1)

   $ —        $ 564       $ —    
  

 

 

    

 

 

    

 

 

 

 

(1) Includes accrued interest expense
Components of Basic and Diluted Earnings per Share

The components of basic and diluted earnings per share were as follows:

 

     2014      2013      2012  

Numerator:

        

Net income attributable to American Vanguard

   $ 4,841       $ 34,449       $ 36,867   
  

 

 

    

 

 

    

 

 

 

Denominator:

Weighted average shares outstanding—basic

  28,436      28,301      27,914   

Dilutive effect of stock options and grants

  476      598      842   
  

 

 

    

 

 

    

 

 

 
  28,912      28,899      28,756   
  

 

 

    

 

 

    

 

 

 
Unamortized Stock Based Compensation Expenses

The below table illustrates the Company’s unamortized stock-based compensation expenses as of December 31, 2014 and December 31, 2013 that will be recognized over the respective weighted average period. This projected expense will change if any stock options and restricted stock are granted or cancelled prior to the respective reporting periods or if there are any changes required to be made for estimated forfeitures.

 

     2014      2013  

Description

   Unamortized
Stock-Based
Compensation
Expenses
     Remaining
Weighted
Average
Period (yrs)
     Unamortized
Stock-Based
Compensation
Expenses
     Remaining
Weighted
Average
Period (yrs)
 

Options

   $ 1,457         3.0       $ 21         0.5   

Performance Based Options

     551         3.0         —          —    

Restricted Stock

     4,829         1.8         5,550         1.9   

Performance Based Restricted Stock

     1,249         2.1         564         2.4   
Summary of Value Option Grants Using Weighted Average Assumptions

The Company uses the Black-Scholes option-pricing model (“Black-Scholes model”) to value option grants using the following weighted average assumptions:

 

     2014  

Risk free interest rate

     2.00

Dividend yield

     0.9

Volatility factor

     48.9

Weighted average life (years)

     6.5 years